A Safety and Efficacy Study of Ispronicline (TC-1734-112) in Subjects With Age Associated Memory Impairment (AAMI)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
The purpose of this Phase II study is to evaluate the efficacy and safety of ispronicline (TC-1734-112) compared to placebo (inactive substance pill) in patients with age associated memory impairment (AAMI). AAMI is characterized as cognitive impairment including memory loss and poor concentration associated with aging.
Epistemonikos ID: d1aa9d363464aa58e808ede2531e682c962d5348
First added on: May 04, 2024